Free shipping on all orders over $ 500

Cadisegliatin (TTP-399)

Cat. No. M21626
Cadisegliatin (TTP-399) Structure
Synonym:

TTP-399

Size Price Availability
5mg USD 300  USD300 1-2 Weeks
10mg USD 480  USD480 1-2 Weeks
25mg USD 950  USD950 1-2 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes. Cadisegliatin did not cause hypoglycemia, had no detrimental effect on plasma lipids or liver enzymes, and did not increase blood pressure, highlighting the importance of tissue selectivity and preservation of physiological regulation when targeting key metabolic regulators such as GK.

Chemical Information
Molecular Weight 455.63
Formula C21H33N3O4S2
CAS Number 859525-02-3
Form Solid
Solubility (25°C) DMSO ≥ 90 mg/mL
Storage 4°C, protect from light
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Related Glucokinase (GK) Products
AZD1092

AZD1092 is an orally active glucokinase (GK) activator with an EC50 value of 0.03 μM.

GKM-001

GKM-001 is a glucokinase (GK) activator that can be used in studies related to type 2 diabetes.

TMG-123

TMG-123 is a glucokinase (GK) activator that can be used in studies related to type 2 diabetes.

PB-201

PB-201 is a glucokinase activator (GKA) that can be used in studies related to type 2 diabetes.

MK-0941 free base 

MK-0941 free base is an orally active glucokinase activator, with EC50s of 240 and 65 nM for recombinant human glucokinase in the presence of 2.5 and 10 mM glucose, respectively. MK-0941 free base exhibits strong glucose-lowering activity and is a potential therapeutic agent for treatment of type 2 diabetes.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cadisegliatin (TTP-399), TTP-399 supplier, Glucokinase (GK), inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.